Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Ovarian Neoplasms

Free Subscription Articles published in Int J Gynaecol Obstet Retrieve available abstracts of 61 articles: HTML format

Single Articles

June 2026
1. GOTTHEIL C, Woolcott C, Marshall EG, Kieser K, et al
   Examining the diagnostic process for ovarian cancer in Nova Scotia: A linked administrative data study.
   Int J Gynaecol Obstet. 2026 Jun 30. doi: 10.1002/ijgo.71149.
   PubMed     Abstract available
   
   
   
2. FANAKI M, Kordali T, Thomakos N, Vlachos DE, et al
   Postoperative decline in CA-125 as a prognostic biomarker in ovarian cancer: A systematic review and meta-analysis.
   Int J Gynaecol Obstet. 2026 Jun 19. doi: 10.1002/ijgo.71146.
   PubMed     Abstract available
   
   
   May 2026
3. CHAO WT, Liu CH, Yang ST, Lin CH, et al
   alpha2,3-Sialyltransferase (ST3Gal1) regulates endometrioid-type epithelial ovarian cancer cell migration and invasion via VEGF-R2/JAK2/STAT3 signaling cascades.
   Int J Gynaecol Obstet. 2026 May 4. doi: 10.1002/ijgo.71057.
   PubMed     Abstract available
   
   
   February 2026
4. SHCHERBATIUK K, Bultmann S, Karn T, Gasimli K, et al
   Diagnostic accuracy of phosphatase and tensin homolog loss in differentiating between atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia and non-atypical endometrial hyperplasia: A systematic review and meta-analysis.
   Int J Gynaecol Obstet. 2026 Feb 26. doi: 10.1002/ijgo.70901.
   PubMed     Abstract available
   
   
   December 2025
5. YONEMORI K, Yunokawa M, Matsumoto K, Takehara K, et al
   Clinical trial of safety and antitumor activity of farletuzumab ecteribulin in patients with platinum-resistant ovarian cancer: Phase I expansion results.
   Int J Gynaecol Obstet. 2025 Dec 23. doi: 10.1002/ijgo.70676.
   PubMed     Abstract available
   
   
   November 2025
6. FUJITA H, Okamoto K, Kato H, Watari H, et al
   Combination of transvaginal ultrasound with cervical cancer screening contributes to early detection of ovarian cancer: Clinical trial.
   Int J Gynaecol Obstet. 2025 Nov 3. doi: 10.1002/ijgo.70599.
   PubMed     Abstract available
   
   
   September 2025
7. ASSAF W, Qarawani A, Abboud Y, Shalabna E, et al
   Pathology results of risk-reducing salpingo-oophorectomy in BRCA1/2 carriers and long-term clinical outcomes.
   Int J Gynaecol Obstet. 2025;170:1188-1198.
   PubMed     Abstract available
   
   
   
8. YANAIHARA N, Tse KY, Lee SJ, Yoo JG, et al
   Immune checkpoint inhibitors in gynecologic oncology: Current status and perspectives.
   Int J Gynaecol Obstet. 2025;171 Suppl 1:166-188.
   PubMed     Abstract available
   
   
   
9. RENZ M, Friedlander M, Berek JS
   Cancer of the ovary, fallopian tube, and peritoneum: 2025 update.
   Int J Gynaecol Obstet. 2025;171 Suppl 1:6-35.
   PubMed     Abstract available
   
   
   August 2025
10. ATILGAN AE, Dilmac AE, Akcaoglu T
    Pseudo-Meigs syndrome owing to a retained fibroid following total laparoscopic hysterectomy for multiple leiomyomas: A case report and review of the literature.
    Int J Gynaecol Obstet. 2025 Aug 14. doi: 10.1002/ijgo.70474.
    PubMed     Abstract available
    
    
    July 2025
11. VO HL, Tran DT, Le LH, Nguyen TTN, et al
    Comparative diagnostic performance of the early-stage ovarian malignancy score versus other risk prediction models in early-stage ovarian cancer: A Vietnamese prospective cohort study.
    Int J Gynaecol Obstet. 2025 Jul 31. doi: 10.1002/ijgo.70383.
    PubMed     Abstract available
    
    
    
12. MCCLUGGAGE WG
    New histopathological and molecular findings in gynecological cancers.
    Int J Gynaecol Obstet. 2025 Jul 30. doi: 10.1002/ijgo.70283.
    PubMed     Abstract available
    
    
    
13. JHANG H, Kim S, Park HT, Shin JY, et al
    Dienogest use and the risk of breast and gynecologic cancers: A nationwide population-based study.
    Int J Gynaecol Obstet. 2025 Jul 29. doi: 10.1002/ijgo.70424.
    PubMed     Abstract available
    
    
    
14. BRENNER S, King T, Roecker Z, Dansby K, et al
    Pediatric ovarian malignancies and outcomes in an urban tertiary care center.
    Int J Gynaecol Obstet. 2025 Jul 21. doi: 10.1002/ijgo.70400.
    PubMed     Abstract available
    
    
    
15. KARATAS E, Salman MC, Basaran D, Akgor U, et al
    Predictors of lymphocyst development following lymphadenectomy in patients with gynecologic cancer.
    Int J Gynaecol Obstet. 2025 Jul 17. doi: 10.1002/ijgo.70377.
    PubMed     Abstract available
    
    
    
16. LI M, Xu S, Yang Q, Zheng Z, et al
    Epidemiological trends of gynecologic cancer burden in east Asian countries from 1990 to 2021 and projections to 2031.
    Int J Gynaecol Obstet. 2025 Jul 4. doi: 10.1002/ijgo.70351.
    PubMed     Abstract available
    
    
    
17. GU X, Jiang L, Xu C, Yin J, et al
    Nomogram prediction model based on non-enhanced computed tomography for adnexal torsion: A retrospective multicenter study.
    Int J Gynaecol Obstet. 2025;170:188-199.
    PubMed     Abstract available
    
    
    June 2025
18. CHERUVATHUR JS, Levin G, Ribeiro R, Racovitan F, et al
    Revisiting intraperitoneal chemotherapy for advanced high-grade serous ovarian cancer.
    Int J Gynaecol Obstet. 2025 Jun 26. doi: 10.1002/ijgo.70336.
    PubMed     Abstract available
    
    
    
19. ARENA A, Franceschini C, Mantovani E, Virgilio A, et al
    Conservative hysteroscopic treatment of endometrial intraepithelial neoplasia and endometrial cancer in patients with high surgical risk with mechanical hysteroscopic tissue removal systems: A retrospective cohort study.
    Int J Gynaecol Obstet. 2025 Jun 18. doi: 10.1002/ijgo.70320.
    PubMed     Abstract available
    
    
    April 2025
20. VARGHESE S, Lim MC, Armbrust R, Pareja R, et al
    Worldwide barriers of optimal surgical care provision in advanced ovarian cancer.
    Int J Gynaecol Obstet. 2025 Apr 25. doi: 10.1002/ijgo.70033.
    PubMed     Abstract available
    
    
    
21. STRANDELL A, Sundfeldt K, Palsson M, Collins E, et al
    Letter to the editor: FIGO Position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Int J Gynaecol Obstet. 2025 Apr 23. doi: 10.1002/ijgo.70188.
    PubMed    
    
    
    February 2025
22. KANG J, Mei D, Xing X, Cao Y, et al
    Characteristics and prognostic implications of a cohort of 50 Sertoli-Leydig cell tumors at a single center.
    Int J Gynaecol Obstet. 2025;168:613-619.
    PubMed     Abstract available
    
    
    January 2025
23. ALSHWAYYAT S, Abo-Elnour DE, Dabash TY, Alshwayyat TA, et al
    Personalized approach to malignant struma ovarii: Insights from a web-based machine learning tool.
    Int J Gynaecol Obstet. 2025;168:343-352.
    PubMed     Abstract available
    
    
    December 2024
24. OZCIVIT ERKAN IB, Kuru O, Turker Saricoban C, Wardak M, et al
    Unusual synchronous and metachronous association of hematologic neoplasms with gynecologic neoplasms: A case series and literature review.
    Int J Gynaecol Obstet. 2024 Dec 6. doi: 10.1002/ijgo.16075.
    PubMed     Abstract available
    
    
    November 2024
25. BASARIR ZO, Caydere M, Karabulut S, Kotanoglu MS, et al
    The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome.
    Int J Gynaecol Obstet. 2024 Nov 30. doi: 10.1002/ijgo.16071.
    PubMed     Abstract available
    
    
    
26. NHA PB, Tu NP, Ha NV, Hien DTT, et al
    Anti-NMDA receptor autoimmune encephalitis associated with ovarian teratoma: A case series and literature review.
    Int J Gynaecol Obstet. 2024 Nov 23. doi: 10.1002/ijgo.16028.
    PubMed     Abstract available
    
    
    
27. HERAS M, Azcona L, Arencibia O, Minig L, et al
    Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study.
    Int J Gynaecol Obstet. 2024 Nov 14. doi: 10.1002/ijgo.16026.
    PubMed     Abstract available
    
    
    October 2024
28. MOR-HADAR D, Wilailak S, Berek J, McNally OM, et al
    FIGO position statement on opportunistic salpingectomy as an ovarian cancer prevention strategy.
    Int J Gynaecol Obstet. 2024 Oct 16. doi: 10.1002/ijgo.15884.
    PubMed     Abstract available
    
    
    September 2024
29. JU UC, Kang WD, Kim SM
    Enhancing the accuracy of preoperative and intraoperative evaluation of malignant ovarian germ cell tumors with a focus on fertility preservation in young women.
    Int J Gynaecol Obstet. 2024 Sep 15. doi: 10.1002/ijgo.15916.
    PubMed     Abstract available
    
    
    
30. NIE X, Xu T, Cheng W
    Comparative prognosis analysis of ovarian squamous cell carcinoma versus serous carcinoma: Insights from the SEER database.
    Int J Gynaecol Obstet. 2024 Sep 11. doi: 10.1002/ijgo.15899.
    PubMed     Abstract available
    
    
    August 2024
31. LUKAC S, Wenzel R, Schochter F, Friebe-Hoffmann U, et al
    Pregnancy after advanced ovarian cancer with spontaneous uterine rupture in second trimester: A case report and review of the literature.
    Int J Gynaecol Obstet. 2024 Aug 1. doi: 10.1002/ijgo.15837.
    PubMed     Abstract available
    
    
    May 2024
32. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Response: Comment on searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2024 May 20. doi: 10.1002/ijgo.15595.
    PubMed    
    
    
    
33. ROECKER ZA, Young MR, Han C
    Rapidly progressing ascites in a pregnancy with a massive fibroid: A case report and review of pseudo-Meigs syndrome.
    Int J Gynaecol Obstet. 2024 May 12. doi: 10.1002/ijgo.15604.
    PubMed     Abstract available
    
    
    
34. ALIABADI AR, Wilailak S, McNally O, Berek JS, et al
    Contraceptive strategies for reducing the risk of reproductive cancers.
    Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567.
    PubMed     Abstract available
    
    
    
35. BANDHON BZ, Navaneethan S, Patton D
    A case report on the microcystic stromal tumor of the ovary: A rare type of ovarian tumor.
    Int J Gynaecol Obstet. 2024 May 8. doi: 10.1002/ijgo.15580.
    PubMed    
    
    
    
36. TANG Y
    Letter to the editor: Searching for prognostic markers for stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2024 May 7. doi: 10.1002/ijgo.15594.
    PubMed    
    
    
    April 2024
37. SHIM SH, Yang EJ, Jang EB, Lee S, et al
    Prognostic impact of erythropoietin-stimulating agent use during front-line chemotherapy in patients with ovarian cancer: A Korean multicenter cohort study.
    Int J Gynaecol Obstet. 2024 Apr 29. doi: 10.1002/ijgo.15533.
    PubMed     Abstract available
    
    
    
38. MIYAMOTO E, Yoshihara M, Iyoshi S, Mogi K, et al
    Factors affecting the long-term prognosis of patients in the AYA generation with epithelial ovarian cancer: A multicenter propensity score matching analysis.
    Int J Gynaecol Obstet. 2024 Apr 12. doi: 10.1002/ijgo.15479.
    PubMed     Abstract available
    
    
    March 2024
39. MUTCH D, Gaffney D, Matias-Guiu X, Fotopoulou C, et al
    Response: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15478.
    PubMed    
    
    
    
40. SEGOVIA JM, Cantor EA, Vargas HA, Sanabria DE, et al
    Letter to the Editor: Analysis of adjuvant therapy in early staged endometrioid endometrial cancer-FIGO 2023 classification.
    Int J Gynaecol Obstet. 2024 Mar 21. doi: 10.1002/ijgo.15475.
    PubMed    
    
    
    January 2024
41. BRENT SE, McGee J, Vicus D, Kim R, et al
    Rates of genetic consultation in high-grade serous ovarian cancer patients in the era of PARP inhibitor therapy: A population-based study.
    Int J Gynaecol Obstet. 2024 Jan 29. doi: 10.1002/ijgo.15391.
    PubMed     Abstract available
    
    
    
42. WANG J, Du Y, Kang Y
    Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study.
    Int J Gynaecol Obstet. 2024 Jan 11. doi: 10.1002/ijgo.15338.
    PubMed     Abstract available
    
    
    December 2023
43. DEMISSIE L, Birara M, Tolu LB, Sium AF, et al
    Recurrent ovarian cancer in Africa: Rate and associated factors at a gynecologic oncology treatment center in Ethiopia-A cross-sectional study.
    Int J Gynaecol Obstet. 2023 Dec 26. doi: 10.1002/ijgo.15316.
    PubMed     Abstract available
    
    
    November 2023
44. LUO L, Xu N, Liu Y, Zhong S, et al
    Prognostic factors and novel nomograms for overall survival and cancer specific survival of malignant ovarian cancer patients with bone metastasis: A SEER-based study.
    Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15261.
    PubMed     Abstract available
    
    
    
45. WANG D, Ran X, He Y, Zhu L, et al
    Nomograms for predicting overall survival and cancer-specific survival of endometrioid ovarian carcinoma: A retrospective cohort study from the SEER database.
    Int J Gynaecol Obstet. 2023 Nov 27. doi: 10.1002/ijgo.15263.
    PubMed     Abstract available
    
    
    
46. GAO C, Han Y, Fan X, Dong H, et al
    A case of unilateral sclerosing stromal tumor of the ovary in a postmenopausal female.
    Int J Gynaecol Obstet. 2023 Nov 12. doi: 10.1002/ijgo.15221.
    PubMed    
    
    
    
47. MA X, Xu L, Ma F, Zhang J, et al
    Whole-tumor apparent diffusion coefficient histogram analysis for preoperative risk stratification in endometrial endometrioid adenocarcinoma.
    Int J Gynaecol Obstet. 2023 Nov 4. doi: 10.1002/ijgo.15226.
    PubMed     Abstract available
    
    
    
48. RATHAT G, Blay L, Bakenga J, Roggen N, et al
    Scarless preventive surgery.
    Int J Gynaecol Obstet. 2023;163:701-702.
    PubMed    
    
    
    September 2023
49. EL HAYEK P, Chlala W, Younes K, Ghaname W, et al
    Severe hemoperitoneum from spontaneous rupture of uterine tumor resembling ovarian sex-cord tumor: A very rare case.
    Int J Gynaecol Obstet. 2023 Sep 25. doi: 10.1002/ijgo.15151.
    PubMed    
    
    
    
50. AYHAN A, Tunc M, Akilli H, Haberal N, et al
    Fertility-sparing approach to malignant ovarian germ cell tumors - Oncologic and obstetric outocome: A retrospective study.
    Int J Gynaecol Obstet. 2023 Sep 22. doi: 10.1002/ijgo.15141.
    PubMed     Abstract available
    
    
    
51. ANDERSON D, Garcia K, Fang W, Duenas-Garcia O, et al
    Feasibility of opportunistic salpingectomy at the time of a vNOTES hysterectomy: A retrospective cohort.
    Int J Gynaecol Obstet. 2023 Sep 3. doi: 10.1002/ijgo.15085.
    PubMed    
    
    
    July 2023
52. BORELLA F, Bertero L, Valabrega G, Fucina S, et al
    Searching for prognostic markers for Stage I epithelial ovarian cancer: A role for systemic inflammatory markers.
    Int J Gynaecol Obstet. 2023 Jul 27. doi: 10.1002/ijgo.15014.
    PubMed     Abstract available
    
    
    
53. LAVECCHIA M, Dubey A, Jimenez W, Reade CJ, et al
    Intraoperative predictors of appendiceal abnormalities in patients with mucinous ovarian neoplasms.
    Int J Gynaecol Obstet. 2023 Jul 24. doi: 10.1002/ijgo.15008.
    PubMed     Abstract available
    
    
    June 2023
54. MANDATO VD, Torricelli F, Mastrofilippo V, Pellegri C, et al
    Impact of 2 years of COVID-19 pandemic on ovarian cancer treatment in IRCCS-AUSL of Reggio Emilia.
    Int J Gynaecol Obstet. 2023 Jun 26. doi: 10.1002/ijgo.14937.
    PubMed     Abstract available
    
    
    
55. LOPEZ-GONZALEZ E, Rodriguez-Jimenez A, Gomez-Salgado J, Daza-Manzano C, et al
    Role of tumor volume in endometrial cancer: An imaging analysis and prognosis significance.
    Int J Gynaecol Obstet. 2023 Jun 23. doi: 10.1002/ijgo.14954.
    PubMed     Abstract available
    
    
    
56. BEREK JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, et al
    FIGO staging of endometrial cancer: 2023.
    Int J Gynaecol Obstet. 2023 Jun 20. doi: 10.1002/ijgo.14923.
    PubMed     Abstract available
    
    
    May 2023
57. EL-TAWAB SS, Kehoe S
    Synchronous ovarian and Bartholin gland carcinoma: Case report and review of literature.
    Int J Gynaecol Obstet. 2023 May 23. doi: 10.1002/ijgo.14880.
    PubMed     Abstract available
    
    
    
58. VAN STEIN RM, Sikorska K, van der Aa MA, Sonke GS, et al
    Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.
    Int J Gynaecol Obstet. 2023;161:640-648.
    PubMed     Abstract available
    
    
    April 2023
59. FEGHALY I, Kourie H, Moubarak M, Chouery E, et al
    Genetic profile of borderline ovarian tumors in the Lebanese population by whole-exome sequencing.
    Int J Gynaecol Obstet. 2023 Apr 25. doi: 10.1002/ijgo.14805.
    PubMed     Abstract available
    
    
    January 2023
60. PEEYANANJARASSRI K, Nanthamongkolkul K, Jiamset I, Chusook W, et al
    Impact of appendectomy of a grossly normal appendix on the survival outcomes of mucinous ovarian carcinomas in a tertiary hospital.
    Int J Gynaecol Obstet. 2023 Jan 23. doi: 10.1002/ijgo.14689.
    PubMed     Abstract available
    
    
    December 2022
61. LI Q, Zhang X
    Prediction of high-risk factors for ovarian metastasis in patients with endometrial cancer: A large-sample retrospective case-control study.
    Int J Gynaecol Obstet. 2022 Dec 1. doi: 10.1002/ijgo.14606.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Ovarian Neoplasms is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum